Literature DB >> 22763399

Meta-analysis confirms raised risk of bladder cancer from pioglitazone.

Barbara Kermode-Scott.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22763399     DOI： 10.1136/bmj.e4541

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Cardioprotective Effects of Pioglitazone in Type 2 Diabetes.

Authors:  Devjit Tripathy; Carolina Solis-Herrera; Robert E J Ryder
Journal:  Diabetes Spectr       Date:  2021-08-18

Review 2.  Environmental non-occupational risk factors associated with bladder cancer.

Authors:  J Ferrís; O Berbel; J Alonso-López; J Garcia; J A Ortega
Journal:  Actas Urol Esp       Date:  2013-04-22       Impact factor: 0.994

Review 3.  Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?

Authors:  Jean-Luc Faillie; Pierre Petit; Jean-Louis Montastruc; Dominique Hillaire-Buys
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 4.  Diabetic nephropathy: diagnosis and treatment.

Authors:  Daniel Fineberg; Karin A M Jandeleit-Dahm; Mark E Cooper
Journal:  Nat Rev Endocrinol       Date:  2013-10-08       Impact factor: 43.330

5.  Response: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).

Authors:  Sun Ok Song; Kwang Joon Kim; Byung-Wan Lee
Journal:  Diabetes Metab J       Date:  2012-12-12       Impact factor: 5.376

Review 6.  Type 2 Diabetes and Breast Cancer: The Interplay between Impaired Glucose Metabolism and Oxidant Stress.

Authors:  Patrizia Ferroni; Silvia Riondino; Oreste Buonomo; Raffaele Palmirotta; Fiorella Guadagni; Mario Roselli
Journal:  Oxid Med Cell Longev       Date:  2015-06-11       Impact factor: 6.543

Review 7.  Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review.

Authors:  Matthew G Cehic; Nishant Nundall; Jerry R Greenfield; Peter S Macdonald
Journal:  J Transplant       Date:  2018-01-29

Review 8.  Pharmacogenetics and personalized treatment of type 2 diabetes.

Authors:  Sabina Semiz; Tanja Dujic; Adlija Causevic
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.